Product Information
CAROSPIR 25 MG/5 ML SUSPENSION is a brand product labeled by CMP Pharma, Inc., priced at $3.4521 per ML under NDC 46287002004. Its NADAC has been published 307 times since Nov 18, 2020.
FDA first approved this application on Aug 4, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/5mL
Manufacturer
CMP Pharma, Inc.NDC
46287002004
Classification
Brand
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SPIRONOLACTONEApproval Type
New Drug (NDA)
FDA Application
NDA209478FDA Approved
8/4/2017
TE Code
AB
On Market Since
8/4/2017
Pharmacological Classes
Price Statistics
The NADAC for CAROSPIR 25 MG/5 ML SUSPENSION has been published 307 times since Nov 18, 2020, and over the history we have for it it has risen 20.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.4521 per ML |
|---|---|
| All-time high | $3.5466 (Oct 15, 2025) |
| All-time low | $2.8763 (Nov 18, 2020) |
| 52-week high | $3.5466 |
| 52-week low | $3.4521 |
| Median price | $3.3644 |
| Average price | $3.3149 |
| Largest weekly change | +9.0% (Oct 12, 2022) |
| Weeks tracked | 307 |
| Tracking since | Nov 18, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the CaroSpir market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
CMP Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CaroSpir market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aldosterone Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CAROSPIR 25 MG/5 ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for CAROSPIR 25 MG/5 ML SUSPENSION, manufactured by CMP Pharma, Inc., is $3.4521 per ML (NDC 46287002004), effective Sep 30, 2026.
How has the price of CAROSPIR 25 MG/5 ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for CAROSPIR 25 MG/5 ML SUSPENSION has risen 20.0%. It has been tracked across 307 weekly CMS publications since Nov 18, 2020.
What are the highest and lowest recorded NADAC prices for CAROSPIR 25 MG/5 ML SUSPENSION?
Since Nov 18, 2020, the NADAC for CAROSPIR 25 MG/5 ML SUSPENSION has ranged from a low of $2.8763 (Nov 18, 2020) to a high of $3.5466 (Oct 15, 2025), with a median of $3.3644 per ML.
Are there cheaper alternatives to CAROSPIR 25 MG/5 ML SUSPENSION?
No other NADAC-published product currently shares the active ingredient and strength of CAROSPIR 25 MG/5 ML SUSPENSION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CAROSPIR 25 MG/5 ML SUSPENSION?
CAROSPIR 25 MG/5 ML SUSPENSION (NDC 46287002004) is labeled by CMP Pharma, Inc., and CMS classifies it as a brand product.